MRD Monitoring by Multiparametric Flow Cytometry in AML: Is It Time to Incorporate Immune Parameters?

MLA

Pessach, Ilias, et al. “MRD Monitoring by Multiparametric Flow Cytometry in AML: Is It Time to Incorporate Immune Parameters?” Cancers, vol. 14, no. 17, Sept. 2022. EBSCOhost, https://doi.org/10.3390/cancers14174294.

APA

Pessach, I., Spyropoulos, T., Lamprianidou, E., & Kotsianidis, I. (2022). MRD Monitoring by Multiparametric Flow Cytometry in AML: Is It Time to Incorporate Immune Parameters? Cancers, 14(17). https://doi.org/10.3390/cancers14174294

Chicago

Pessach, Ilias, Theodoros Spyropoulos, Eleftheria Lamprianidou, and Ioannis Kotsianidis. 2022. “MRD Monitoring by Multiparametric Flow Cytometry in AML: Is It Time to Incorporate Immune Parameters?” Cancers 14 (17). doi:10.3390/cancers14174294.